A carregar...

Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation

AIMS: Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those with anthracycline‐induced cardiomyopathy are comparable with other...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Guha, Avirup, Caraballo, Cesar, Jain, Prantesh, Miller, P. Elliott, Owusu‐Guha, Jocelyn, Clark, Katherine A.A., Velazquez, Eric J., Ahmad, Tariq, Baldassarre, Lauren A., Addison, Daniel, Weintraub, Neal L., Desai, Nihar R.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318466/
https://ncbi.nlm.nih.gov/pubmed/33982867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!